Vaccines

US Lawmakers Urge RFK Jr. to Avoid Influence on Vaccine Policies

9 days ago

In a surprising yet significant development, a group of lawmakers in the United States have voiced their concerns regarding Robert F. Kennedy Jr.'s involvement in vaccine policy decisions. The politician and environmental attorney, known for his controversial stance on vaccines, has recently been suggested to steer clear of legislative discussions and decisions surrounding immunization policies.

RFK Jr. Opens Door to Vaccines: A New Perspective on Public Health

12 days ago

In an unexpected twist in the ongoing discussion surrounding vaccines, Robert F. Kennedy Jr., the well-known environmental attorney and vaccine skeptic, declared that he would consider supporting vaccines if provided with compelling evidence. This statement marks a notable shift in his long-held stance against vaccination, igniting conversations across medical and political circles.

RFK Jr. Modifies Vaccine Stance Ahead of HHS Senate Testimonies

15 days ago

In a significant turn of events, Robert F. Kennedy Jr. has publicly adjusted his previously staunch rhetoric regarding vaccines as he prepares for upcoming Senate hearings with the Department of Health and Human Services (HHS). This shift comes amid a backdrop of intense scrutiny and debate surrounding health policy and vaccine efficacy, marking a notable moment in both Kennedy's political journey and the broader discourse on public health measures.

RFK Jr. Seeks Republican Support for Key Health Position Amid Political Maneuvering

2 months ago

In an intriguing political maneuver, Robert F. Kennedy Jr. is reaching out to Republican leaders as he aims to secure a prominent position in the health sector. His candidacy comes as he positions himself as a unique candidate who spans across party lines, garnering attention from voters disillusioned with traditional politics.

Market Shockwaves: Vaccine Manufacturer Stocks Plummet as Trump Appoints RFK Jr. to Head HHS

3 months ago

In a surprising political move that has sent ripples through the pharmaceutical industry, former President Donald Trump has appointed Robert F. Kennedy Jr. as the new head of the Department of Health and Human Services (HHS). This unexpected selection has led to an immediate downturn in the stock prices of major vaccine manufacturers, reflecting investor concerns over Kennedy's controversial stance on vaccines.

Merck Adjusts Sales Forecast Amid Slowing Demand for Gardasil Vaccine in China

3 months ago

In a recent update, Merck & Co. has revised its sales outlook downward, largely attributed to subpar demand for its Gardasil vaccine in the Chinese market. The pharmaceutical giant is now bracing for a potential decline in sales as the uptake of their human papillomavirus (HPV) vaccine fails to meet projections.

GSK's Vaccine Sales Decline Dims Profit Outlook Despite Strong Earnings

3 months ago

GlaxoSmithKline (GSK), the prominent British pharmaceutical giant, has reported a noticeable drop in its vaccine sales, which has raised concerns over future profitability. Despite achieving strong profits in the third quarter, the company’s reduced sales in the vaccines sector are overshadowing these positive financial results, signaling potential challenges ahead for one of its key revenue streams.

CDC Panel Endorses Broader Use of Pfizer and Merck Pneumococcal Vaccines

4 months ago

In a significant move aimed at enhancing public health, a panel of experts from the Centers for Disease Control and Prevention (CDC) has recommended the wider utilization of pneumococcal vaccines developed by Pfizer and Merck. This decision is seen as a pivotal step in combating pneumococcal disease, which can lead to serious infections like pneumonia, meningitis, and bloodstream infections.